Ascorbic acid 200mg tablets

Country: United Kingdom

Language: English

Source: MHRA (Medicines & Healthcare Products Regulatory Agency)

Active ingredient:

Ascorbic acid

Available from:

Kent Pharma (UK) Ltd

ATC code:

A11GA01

INN (International Name):

Ascorbic acid

Dosage:

200mg

Pharmaceutical form:

Oral tablet

Administration route:

Oral

Class:

No Controlled Drug Status

Prescription type:

Valid as a prescribable product

Product summary:

BNF: 09060301; GTIN: 5015201009542

Patient Information leaflet

piega 35 mm
piega 35 mm
280 mm
150 mm
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
ASCORBIC ACID 100MG, 200MG AND 500MG TABLETS
Ascorbic acid
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU. Always take this medicine exactly as
described in this leaflet or as your
doctor or pharmacist has told you. • KEEP THIS LEAFLET. YOU MAY NEED TO READ IT AGAIN. • ASK YOUR PHARMACIST IF YOU NEED MORE INFORMATION OR ADVICE. IF
YOU GET ANY SIDE EFFECTS, TALK TO YOUR DOCTOR OR PHARMACIST. THIS INCLUDES ANY POSSIBLE SIDE EFFECTS
NOT LISTED IN THIS LEAFLET. SEE SECTION 4. • YOU MUST TALK TO A DOCTOR IF YOU DO NOT FEEL BETTER OR IF YOU
FEEL WORSE. WHAT IS IN THIS LEAFLET
1. What Ascorbic Acid is and what it is used for
2. What you need to know before you take Ascorbic Acid
3. How to take Ascorbic Acid
4. Possible side effects
5. How to store Ascorbic Acid
6. Contents of the pack and other information
IF YOU STOP TAKING ASCORBIC ACID
Keep taking this medicine until your doctor or
pharmacist tells you to stop. You may need to
stop taking the tablets slowly as they may alter
your kidney function.
If you have any further questions on the use of
this medicine, ask your doctor or pharmacist. POSSIBLE SIDE EFFECTS
Like all medicines, this medicine can cause
side effects, although not everybody gets
them.
STOP TAKING THIS MEDICINE IMMEDIATELY AND
CONSULT YOUR DOCTOR IF YOU SUFFER AN ALLERGIC
REACTION AFTER TAKING THIS MEDICINE. An
allergic reaction may include itching, a rash,
swelling of the face, lips, tongue and/or throat
with difficulty in swallowing or breathing.
IF YOU EXPERIENCE ANY OF THE FOLLOWING YOU
SHOULD SEE YOUR DOCTOR OR PHARMACIST:
•
diarrhoea, stomach cramps, nausea
(feeling sick), vomiting (being sick)
•
flushing or redness of the skin
•
haemolytic anaemia (where the body’s
immune system attacks its own red blood
cells), signs may include fatigue and
paleness
•
diuretic effect (increased urine flow) due
to increased intake of ascorb

Summary of Product characteristics

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Ascorbic Acid 200mg Tablets
Vodexo 200mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 200mg ascorbic acid.
Excipients with known effect: contains 1.20 mg/tablet lactose
monohydrate
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
White to off-white uncoated tablets.
Ascorbic Acid 200mg Tablets are 9.5 mm, white to off-white, plain,
round,
biconvex tablets.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Vitamin C deficiency
Treatment of scurvy
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
_Adults: _
Therapeutic use – at least 250mg daily in divided doses._ _
Maximum of 1000mg daily.
_Elderly: _
As for other adults. As the dietary intake of vitamin C may be
less in the elderly, they have greater risk of presenting with vitamin
C
deficiency.
Method of administration
For oral administration.
4.3
CONTRAINDICATIONS
Ascorbic acid should not be given to patients with hyperoxaluria.
Hypersensitivity to the active substance or to any of the excipients
listed in section
6.1.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Increased intake of ascorbic acid over a prolonged period may result
in
increased renal clearance of ascorbic acid, and deficiency may result
if the
intake is reduced or withdrawn rapidly. (See section 4.8)
Interference with serological testing
Ascorbic acid may interfere with tests and assays for urinary glucose,
giving false-negative results with methods utilising glucose oxidase
with
indicator (e.g. Labstix, Testape) and false- positive results with
neocuproin methods.
Estimation of uric acid by phosphotungstate or uricase with copper
reduction and measurement of creatinine in non-deproteinised serum may
also be affected.
High doses of ascorbic acid may give false-negative readings in faecal
occult
blood tests.
This product contains lactose. Patients with rare hereditary problems
of
galactose intolerance, the Lapp lactase deficiency or
glucose-galactose
malabsorption should not ta